肌肉内注射rAAV2-retro用于低运动神经元转导:评估五种促进剂
Xueqi Gong1,2, Haitong Gao1,2, Wenyuan Wang3,4
1Laboratory Animal Center, Fudan University, Shanghai 200032, China.
International journal of medical sciences
|February 24, 2025
概括
再组合腺相关病毒载体 (rAAVs) 有效地将基因传递到脑干和脊髓的下部运动神经元 (LMN). CAG和hCMV促进体显示出最高的基因表达,而不会引起毒性,优化了对运动神经元疾病的基因传递.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 复合腺相关病毒载体 (rAAVs) 是有效的转基因传递到神经系统.
- 促进者选择对于转基因表达强度和细胞特异性至关重要.
- 之前的研究表明,rAAV2-retro通过肌肉内注射向新生小鼠的下部运动神经元 (LMN).
研究的目的:
- 确定中央神经系统 (CNS) 中rAAV2-反转介导的转基因表达的最佳促进物.
- 为了比较五种常见促进剂的疗效:mPGK,CAG,hCMV,CBA和hSyn.
- 评估rAAV2-复原基因传递给LMN的安全性和细胞特异性.
主要方法:
- 在新生儿C57BL/6J小鼠体内注射rAAV2-复原载体与不同的促进剂.
- 利用光片照明成像和共聚焦显微镜来分析基因表达.
- 确定转化细胞类型和评估基因表达水平.
主要成果:
- rAAV2-retro主要针对中枢神经系统内的脑干和脊髓.
- CAG和hCMV促进体显示出最高的基因表达水平.
- 几乎所有转化细胞都被确定为LMN,没有观察到肝毒性.
结论:
- 在中枢神经系统中,CAG和hCMV是对rAAV2-反向介导的基因传递到LMN的优质促进剂.
- 这项研究为优化运动神经元疾病的基因传递策略提供了关键数据.
- 对LMN的rAAV2-复原基因传递是安全有效的,具有潜在的治疗应用.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...


